Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer (Q46972019)
Jump to navigation
Jump to search
scientific article published in October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer |
scientific article published in October 2007 |
Statements
1 reference
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer (English)
1 reference
1 reference
Roy S Herbst
1 reference
Vincent J O'Neill
1 reference
Louis Fehrenbacher
1 reference
Philip D Bonomi
1 reference
Lowell Hart
1 reference
Ostap Melnyk
1 reference
David Ramies
1 reference
Ming Lin
1 reference
Alan Sandler
1 reference
1 October 2007
1 reference
25
1 reference
30
1 reference
4743-4750
1 reference